PREMIER HEALTH OF AMERICA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.44 CAD | 0.00% |
|
0.00% | +2.33% |
| Apr. 08 | Premier Health of America Inc. Announces Chief Technology Officer Changes | CI |
| Feb. 26 | Premier Health of America Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 | CI |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The company shows low valuation levels, with an enterprise value at 0.39 times its sales.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
Ratings chart - Surperformance
Sector: Software
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +2.33% | 17.88M | - | ||
| -19.16% | 216B | B | ||
| -10.77% | 65.35B | B- | ||
| -3.97% | 56.04B | B | ||
| -1.99% | 39.8B | C | ||
| -7.07% | 33.99B | B | ||
| -9.54% | 28.66B | B | ||
| +116.89% | 28.44B | - | ||
| +2.88% | 21.55B | B | ||
| +3.86% | 13.77B | D+ |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
-
Finances
Valuation
P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality
-
- Stock Market
- Equities
- PHA Stock
- Ratings Premier Health of America Inc.